100 related articles for article (PubMed ID: 11282107)
1. Phenol derivatives accelerate inactivation kinetics in one inactivation-deficient mutant human skeletal muscle Na(+) channel.
Haeseler G; Piepenbrink A; Bufler J; Dengler R; Hecker H; Aronson J; Piepenbrock S; Leuwer M
Eur J Pharmacol; 2001 Mar; 416(1-2):11-8. PubMed ID: 11282107
[TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent block of normal and mutant muscle sodium channels by 4-Chloro-m-Cresol.
Haeseler G; Leuwer M; Kavan J; Würz A; Dengler R; Piepenbrock S
Br J Pharmacol; 1999 Nov; 128(6):1259-67. PubMed ID: 10578140
[TBL] [Abstract][Full Text] [Related]
3. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
Wang GK; Russell C; Wang SY
J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
[TBL] [Abstract][Full Text] [Related]
4. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
5. Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita.
Fleischhauer R; Mitrovic N; Deymeer F; Lehmann-Horn F; Lerche H
Pflugers Arch; 1998 Oct; 436(5):757-65. PubMed ID: 9716710
[TBL] [Abstract][Full Text] [Related]
6. Voltage-dependent blockade of normal and mutant muscle sodium channels by benzylalcohol.
Haeseler G; Mamarvar M; Bufler J; Dengler R; Hecker H; Aronson JK; Piepenbrock S; Leuwer M
Br J Pharmacol; 2000 Jul; 130(6):1321-30. PubMed ID: 10903972
[TBL] [Abstract][Full Text] [Related]
7. Different effects of mexiletine on two mutant sodium channels causing paramyotonia congenita and hyperkalemic periodic paralysis.
Weckbecker K; Würz A; Mohammadi B; Mansuroglu T; George AL; Lerche H; Dengler R; Lehmann-Horn F; Mitrovic N
Neuromuscul Disord; 2000 Jan; 10(1):31-9. PubMed ID: 10677861
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans.
Bouhours M; Sternberg D; Davoine CS; Ferrer X; Willer JC; Fontaine B; Tabti N
J Physiol; 2004 Feb; 554(Pt 3):635-47. PubMed ID: 14617673
[TBL] [Abstract][Full Text] [Related]
9. The anesthetic propofol modulates gating in paramyotonia congenita mutant muscle sodium channels.
Haeseler G; Störmer M; Mohammadi B; Bufler J; Dengler R; Piepenbrock S; Leuwer M
Muscle Nerve; 2001 Jun; 24(6):736-43. PubMed ID: 11360256
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for voltage-dependent block of muscle sodium channels by phenol derivatives.
Haeseler G; Piepenbrink A; Bufler J; Dengler R; Aronson JK; Piepenbrock S; Leuwer M
Br J Pharmacol; 2001 Apr; 132(8):1916-24. PubMed ID: 11309264
[TBL] [Abstract][Full Text] [Related]
11. Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.
Zamponi GW; French RJ
Biophys J; 1993 Dec; 65(6):2335-47. PubMed ID: 8312473
[TBL] [Abstract][Full Text] [Related]
12. Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis.
Hayward LJ; Brown RH; Cannon SC
Biophys J; 1997 Mar; 72(3):1204-19. PubMed ID: 9138567
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of cold sensitivity of paramyotonia congenita mutation R1448H and overlap syndrome mutation M1360V.
Mohammadi B; Mitrovic N; Lehmann-Horn F; Dengler R; Bufler J
J Physiol; 2003 Mar; 547(Pt 3):691-8. PubMed ID: 12562902
[TBL] [Abstract][Full Text] [Related]
14. Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na(+) channel.
Takahashi MP; Cannon SC
J Physiol; 2001 Dec; 537(Pt 3):701-14. PubMed ID: 11744749
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of the Ile693Thr Na+ channel mutation associated with paramyotonia congenita in a human cell line.
Plassart-Schiess E; Lhuillier L; George AL; Fontaine B; Tabti N
J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):721-7. PubMed ID: 9508833
[TBL] [Abstract][Full Text] [Related]
16. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation.
Chahine M; George AL; Zhou M; Ji S; Sun W; Barchi RL; Horn R
Neuron; 1994 Feb; 12(2):281-94. PubMed ID: 8110459
[TBL] [Abstract][Full Text] [Related]
17. A1152D mutation of the Na+ channel causes paramyotonia congenita and emphasizes the role of DIII/S4-S5 linker in fast inactivation.
Bouhours M; Luce S; Sternberg D; Willer JC; Fontaine B; Tabti N
J Physiol; 2005 Jun; 565(Pt 2):415-27. PubMed ID: 15790667
[TBL] [Abstract][Full Text] [Related]
18. Mutant channels contribute <50% to Na+ current in paramyotonia congenita muscle.
Mitrovic N; George AL; Rüdel R; Lehmann-Horn F; Lerche H
Brain; 1999 Jun; 122 ( Pt 6)():1085-92. PubMed ID: 10356061
[TBL] [Abstract][Full Text] [Related]
19. High-affinity blockade of voltage-operated skeletal muscle sodium channels by 2,6-dimethyl-4-chlorophenol.
Haeseler G; Gudehus S; Bufler J; Dengler R; Leuwer M
Eur J Anaesthesiol; 2006 Mar; 23(3):190-6. PubMed ID: 16430789
[TBL] [Abstract][Full Text] [Related]
20. A human muscle Na+ channel mutation in the voltage sensor IV/S4 affects channel block by the pentapeptide KIFMK.
Peter W; Mitrovic N; Schiebe M; Lehmann-Horn F; Lerche H
J Physiol; 1999 Jul; 518(Pt 1):13-22. PubMed ID: 10373685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
